Filter
756
Filtered Results: 756
Text search:
good
prescribing
practice
Featured
Recommendations
96
New Publications
191
Language
Document type
No document type
378
Guidelines
152
Studies & Reports
123
Manuals
45
Strategic & Response Plan
24
Training Material
16
Fact sheets
9
Situation Updates
4
Resource Platforms
4
Online Courses
1
Countries / Regions
India
47
South Africa
31
Kenya
28
Global
26
Uganda
20
Western and Central Europe
18
Ethiopia
16
Ghana
15
Tanzania
15
Malawi
10
Namibia
10
Nepal
9
Liberia
9
Sierra Leone
8
Rwanda
7
Nigeria
7
Zimbabwe
7
Latin America and the Carribbean
7
Botswana
7
Lesotho
6
Africa
6
Ukraine
5
Haiti
5
Zambia
5
Eswatini/ Swaziland
5
Cameroon
4
South–East Asia Region
4
Eastern Europe and Central Asia
4
Bangladesh
4
Eastern Europe
4
Myanmar / Burma
4
Jordan
3
Western Pacific Region
3
United Kingdom
3
Indonesia
3
Syria
2
Laos
2
Burkina Faso
2
Philippines
2
USA
2
Germany
2
Vietnam
2
Sri Lanka
2
El Salvador
1
Australia
1
China
1
Chile
1
Fiji
1
Senegal
1
Peru
1
Qatar
1
Mozambique
1
Cambodia
1
Asia
1
Congo, Democratic Republic of
1
West and Central Africa
1
Turkmenistan
1
Denmark
1
Argentina
1
Russia
1
Egypt
1
Georgia
1
Mali
1
Libya
1
South Sudan
1
Iraq
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
274
Clinical Guidelines
93
Public Health
54
Women & Child Health
25
Capacity Building
20
Pharmacy & Technologies
5
Key Resources
2
Toolboxes
AMR
126
Mental Health
88
Pharmacy
65
HIV
42
NCDs
33
Caregiver
31
TB
30
Planetary Health
18
Disability
14
COVID-19
10
NTDs
10
Conflict
7
Refugee
5
Global Health Education
4
Rapid Response
3
Specific Hazards
1
Cholera
1
Ebola
1
Health Financing Toolbox
1
Polio
1
The combined effects from ambient (outdoor) air pollution and indoor (household, in particular) air pollution cause approximately 7 million premature deaths every year, largely as a result of increased mortality from stroke, IHD, COPD, lung cancer and acute respiratory infections (1). Air pollution ...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The Global Asthma Report (GAR) 2022, prepared by the Global Asthma Network (GAN), is the fourth such report (others 2011, 2014, 2018). GAN builds upon the work of the International Study of Asthma and Allergies in Childhood (ISAAC) and The International Union Against Tuberculosis and Lung Disease (T...
Asthma is the most common noncommunicable disease in children, and among the most common in adults. According to the most recent estimates from the Global Asthma Network Phase I study, around one in 10 children and adults have symptoms of asthma and one in 20 school-aged children have severe asthma ...
The 2023 meeting of the WHO Clinical Consortium on Healthy Ageing (CCHA) was the group’s ninth gathering and took place in Geneva 5–7 December 2023. The meeting was structured around seven panels, with a series of technical presentations, plenary discussions and group work, and a final session o...
Asthma is the most common chronic condition in children worldwide. It affects daytime activities, sleep and school attendance and causes anxiety to parents, families and other carers. The quality of asthma diagnosis and management globally still needs substantial improvement. From infancy to the tee...
This report provides an overview of the operations and activities of the WHO Country Office in Ukraine in 2023. Despite the acute health impacts of the war in Ukraine, the Country Office continued its work according to its core mandate. WHO supported the Government of Ukraine in managing the health ...
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
The main aim of these guidelines is to enable the central units of national TB and HIV/AIDS programmes to support districts to plan, coordinate and implement collaborative TB/HIV activities. These guidelines reinforce current medical understanding, that highly active antiretroviral treatment (HAART)...
J. European Academy of Dermatology and Venereology, 4 August 2014
Methodological field approaches for scientists with a basic background in entomology to prepare and implement a yellow fever entomological assessment during outbreaks
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
